SCHEMBL17828971

SCHEMBL17828971

c1ccc(-c2nc(-n3c4ccccc4c4c(-c5cccc6c5c5ccccc5n6-c5ccccc5)cccc43)nc3ccc4ccccc4c23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 7/20 0.36
HPGD P15428 5/20 0.36
MAPT P10636 5/20 0.36
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 3/20 0.33
HTT P42858 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
MAPK1 P28482 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
IL1R1 P14778 1/20 0.31
RECQL P46063 1/20 0.31
PTGES O14684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17828966 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL22988550 0.91 KDM4E (0.34) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL22988514 0.89 ALDH1A1 (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL17828974 0.87 ATM (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL24117173 0.87 KDM4E (0.31) KDM4EALDH1A1HPGDMAPTLMNA
SCHEMBL24245551 0.86 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL17828975 0.86 ATM (0.38) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL24117170 0.85 ALDH1A1 (0.36) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL24245622 0.85 ALDH1A1 (0.36) KDM4EL3MBTL1ATMALDH1A1HPGD
SCHEMBL23129517 0.85 KDM4E (0.34) KDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 KDM4E 2236/4885L3MBTL1 271/4885ATM 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.